Maxime Luu

976 total citations
18 papers, 318 citations indexed

About

Maxime Luu is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Maxime Luu has authored 18 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Physiology. Recurrent topics in Maxime Luu's work include Eosinophilic Esophagitis (3 papers), Pregnancy and Medication Impact (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Maxime Luu is often cited by papers focused on Eosinophilic Esophagitis (3 papers), Pregnancy and Medication Impact (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Maxime Luu collaborates with scholars based in France, Canada and Australia. Maxime Luu's co-authors include Marc Bardou, Christophe Michiels, Alan Barkun, Éric Benzenine, Muriel Doret, Catherine Quantin, Kelly M. Cordoro, Inès Ben Ghezala, Paul Sagot and Julie Barberet and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Fertility and Sterility.

In The Last Decade

Maxime Luu

17 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxime Luu France 9 161 133 105 65 40 18 318
Т. Ф Татарчук Ukraine 8 103 0.6× 102 0.8× 43 0.4× 51 0.8× 59 1.5× 119 843
R. Bardi Tunisia 12 62 0.4× 148 1.1× 110 1.0× 96 1.5× 8 0.2× 54 412
J.-L. Pouly France 16 284 1.8× 115 0.9× 146 1.4× 29 0.4× 152 3.8× 68 768
Cihat Ünlü Türkiye 15 149 0.9× 83 0.6× 109 1.0× 27 0.4× 29 0.7× 28 458
Özlem Özdeğirmenci Türkiye 16 235 1.5× 68 0.5× 84 0.8× 18 0.3× 107 2.7× 33 558
Oldřich Pozler Czechia 11 33 0.2× 60 0.5× 163 1.6× 72 1.1× 16 0.4× 19 335
Emilia Escuredo United Kingdom 5 247 1.5× 33 0.2× 28 0.3× 80 1.2× 112 2.8× 9 400
Attila Pajor Hungary 12 77 0.5× 38 0.3× 71 0.7× 27 0.4× 120 3.0× 36 380
Sabahattin Altunyurt Türkiye 15 150 0.9× 67 0.5× 87 0.8× 58 0.9× 169 4.2× 49 579
George Pistofidis Greece 11 88 0.5× 100 0.8× 106 1.0× 20 0.3× 57 1.4× 23 652

Countries citing papers authored by Maxime Luu

Since Specialization
Citations

This map shows the geographic impact of Maxime Luu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Luu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Luu more than expected).

Fields of papers citing papers by Maxime Luu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Luu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Luu. The network helps show where Maxime Luu may publish in the future.

Co-authorship network of co-authors of Maxime Luu

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Luu. A scholar is included among the top collaborators of Maxime Luu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Luu. Maxime Luu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bonniaud, B., Maxime Luu, Catherine Cormier, et al.. (2025). Lack of behavioural improvement with sirolimus in a patient with MTOR-related macrocephaly with pigmentary mosaicism: A new case report. European Journal of Medical Genetics. 75. 105012–105012.
2.
Bardou, Marc, et al.. (2023). Experience and expectations of pharmacogenetic tests in France. Therapies. 79(3). 341–349. 4 indexed citations
3.
Thomas, Quentin, Céline Verstuyft, Émilie Tisserant, et al.. (2022). Exome sequencing allows detection of relevant pharmacogenetic variants in epileptic patients. The Pharmacogenomics Journal. 22(5-6). 258–263. 1 indexed citations
4.
Ghezala, Inès Ben, Maxime Luu, & Marc Bardou. (2022). An update on drug–drug interactions associated with proton pump inhibitors. Expert Opinion on Drug Metabolism & Toxicology. 18(5). 337–346. 21 indexed citations
5.
Luu, Maxime, et al.. (2022). First use of Simulation in Therapeutic Patient Education (S-TPE) in adults with diabetes: a pilot study. BMJ Open. 12(2). e049454–e049454. 3 indexed citations
6.
Thiyagarajan, Karthick, et al.. (2022). Intelligent Guide Robots for People who are Blind or have Low Vision: A Review. 13(1). 1–15. 5 indexed citations
7.
Ghezala, Inès Ben, et al.. (2021). Small Molecule Drugs in Inflammatory Bowel Diseases. Pharmaceuticals. 14(7). 637–637. 22 indexed citations
8.
Guibaud, Laurent, Alexis Arzimanoglou, Arthur Sorlin, et al.. (2020). Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation. European Journal of Medical Genetics. 63(11). 104036–104036. 7 indexed citations
9.
Luu, Maxime, Éric Benzenine, Alan Barkun, et al.. (2019). Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti‐TNFα agents: a French nationwide population‐based cohort. Alimentary Pharmacology & Therapeutics. 50(11-12). 1181–1188. 17 indexed citations
10.
Gabrielle, Pierre‐Henry, et al.. (2018). Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(3). 461–467. 13 indexed citations
11.
Luu, Maxime, Éric Benzenine, Muriel Doret, et al.. (2018). Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION). The American Journal of Gastroenterology. 113(11). 1669–1677. 128 indexed citations
12.
Chevallier, Olivier, Maxime Luu, Marianne Latournerie, et al.. (2018). Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation. Quantitative Imaging in Medicine and Surgery. 8(2). 174–181. 3 indexed citations
13.
Bardou, Marc, Kyle J. Fortinsky, Nicolas Chapelle, Maxime Luu, & Alan Barkun. (2018). An update on the latest chemical therapies for reflux esophagitis in children. Expert Opinion on Pharmacotherapy. 20(2). 231–239. 7 indexed citations
14.
15.
Bruno, Céline, Maxime Luu, Julie Barberet, et al.. (2016). Embryo multinucleation at the two-cell stage is an independent predictor of intracytoplasmic sperm injection outcomes. Fertility and Sterility. 107(1). 97–103.e4. 37 indexed citations
16.
Bardou, Marc, et al.. (2016). Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo®) in Achieving Intramuscular Agent Delivery: An Observational Study. Advances in Therapy. 34(1). 252–260. 11 indexed citations
17.
Luu, Maxime, Marc Bardou, Philippe Bonniaud, & Françoise Goirand. (2016). Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma. Expert Opinion on Drug Metabolism & Toxicology. 12(12). 1503–1511. 14 indexed citations
18.
Luu, Maxime & Kelly M. Cordoro. (2013). The evolving role of biologics in the treatment of pediatric psoriasis.. PubMed. 18(2). 1–4. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Т. Ф Татарчук Breakdown of academic impact, for papers by R. Bardi Breakdown of academic impact, for papers by J.-L. Pouly Breakdown of academic impact, for papers by Cihat Ünlü Breakdown of academic impact, for papers by Özlem Özdeğirmenci Breakdown of academic impact, for papers by Oldřich Pozler Breakdown of academic impact, for papers by Emilia Escuredo Breakdown of academic impact, for papers by Attila Pajor Breakdown of academic impact, for papers by Sabahattin Altunyurt Breakdown of academic impact, for papers by George Pistofidis
Rankless by CCL
2026